supported by Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences(No.CI2021B015);the Fundamental Research Funds for the Central Public Welfare Research Institutes(JJPY2022017).
Background:Pudilan Xiaoyan Oral Liquid(PDL)is a Chinese patent medicine with notable pharmacological properties,including anti-inflammatory and antibacterial effects.Drug-resistant Pseudomonas aeruginosa infection is ...
funded by the National Key R and D Program of China (2018YFC1706900, 2018YFC1706902);“Double First-Class” University project of China Pharmaceutical University (CPU2018GF07, CPU2018PZQ19);Jiangsu Provincial Administration of Traditional Chinese Medicine (YB201819);the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. SKLNMZZ202025)
Objective: Allergic asthma(AA) is a chronic airway infiammatory disease characterized by airway hyper-responsiveness(AHR). Pudilan anti-infiammatory oral liquid(PDL), along with its main medicinal material, Taraxaci H...
supported by the National Natural Science Foundation of China(No.81774204);Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences(No.CI2021A04608)。
Background:Pudilan Xiaoyan Oral Liquid(PDL),a famous traditional Chinese formula for treating acute and chronic inflammation.To evaluate the broad-spectrum antiviral effect of Pudilan Xiaoyan Oral Liquid,and provide a...
National Key Research&Development Plan Project(2018YFC1707400,2018YFC1707410);Research Funding Project For Graduate Education Teaching Reform of China Academy of Chinese Medical Sciences(JG201703)
To systematically evaluate the efficacy and safety of Pudilan Xiaoyan Oral in Liquid(蒲地蓝消炎口服液)in the treatment of suppurative tonsillitis in children.In WanFang,CNKI,VIP,CBM,PubMed,Embase and Corchrane and oth...